2024 Older MRD vs. younger MUD in patients older than 50 years with AML in remission using post-transplant cyclophosphamide Group Acute Leukemia Working Party (ALWP) 1st listed author Simona Piemontese Journal Leukemia.
2024 Younger unrelated donors may be preferable over HLA match in the PTCy era: a study from the ALWP of the EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Jaime Sanz Journal Blood.
2024 Prognostic impact of number of induction courses to attain complete remission in patients with acute myeloid leukemia transplanted with either a matched sibling or human leucocyte antigen 10/10 or 9/10 unrelated donor: An Acute Leukemia Working Party European Society for Blood and Marrow Transplantation study Group Acute Leukemia Working Party (ALWP) 1st listed author Justin Loke Journal Cancer.
2024 Improvements in Posttransplant Outcomes Over Two Decades in Older Patients with Acute Myeloid Leukemia in the EBMT ALWP Study Group Acute Leukemia Working Party (ALWP) 1st listed author Ali Bazarbachi Journal Clin Cancer Res.
2024 Haploidentical stem cell donor choice for patients with acute myeloid leukemia: a study from the ALWP of the EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Jaime Sanz Journal Blood Adv.
2024 Guidelines for the management of Toxoplasma gondii infection and disease in patients with haematological malignancies and after haematopoietic stem-cell transplantation: guidelines from the 9th European Conference on Infections in Leukaemia, 2022 Group Infectious Diseases Working Party (IDWP) Other society 1st listed author Robina Aerts Journal Lancet Infect Dis.
2024 Performance of the beta-glucan test for the diagnosis of invasive fusariosis and scedosporiosis: a meta-analysis Group Infectious Diseases Working Party (IDWP) 1st listed author Frederic Lamoth Journal Med Mycol.
2024 Extended clinical phenotypes and treatment modalities in 32 JAGN1-deficient patients. A multicenter study by EBMT IEWP Group Inborn Errors Working Party (IEWP) 1st listed author Julia Fekadu-Siebald Journal Blood Adv.
2024 Outcomes of HLA-mismatched HSCT with TCRαβ/CD19 depletion or post-HSCT cyclophosphamide for inborn errors of immunity Group Inborn Errors Working Party (IEWP) 1st listed author Su Han Lum Journal Blood.
2024 Permissible HLA mismatches in 9/10 unrelated donor pediatric stem cell transplants using HLA-EMMA: an EBMT Inborn Errors Working Party study Group Inborn Errors Working Party (IEWP) 1st listed author Erik G J von Asmuth Journal Blood Adv.
2024 Comparison of fludarabine/melphalan (FM140) with fludarabine/melphalan/BCNU (FBM110) in patients with relapsed/refractory AML undergoing allogeneic hematopoietic cell transplantation - a registry study on behalf of the EBMT Acute Leukemia Working Party Group Acute Leukemia Working Party (ALWP) 1st listed author Jesús Duque-Afonso Journal Bone Marrow Transplant.
2024 Immune checkpoint inhibitors therapy for solid organ malignancies after allogeneic hematopoietic stem cell transplantation: a retrospective study from the EBMT Transplant Complications Working Party Group Transplant Complications Working Party (TCWP) 1st listed author J Brijs Journal Bone Marrow Transplant.